Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 2
2009 5
2010 3
2011 1
2012 4
2013 2
2014 1
2015 7
2016 5
2017 10
2018 9
2019 19
2020 8
2021 8
2022 16
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B, Oyervides Juárez VM, Hsieh JJ, Basso U, Shah AY, Suárez C, Hamzaj A, Goh JC, Barrios C, Richardet M, Porta C, Kowalyszyn R, Feregrino JP, Żołnierek J, Pook D, Kessler ER, Tomita Y, Mizuno R, Bedke J, Zhang J, Maurer MA, Simsek B, Ejzykowicz F, Schwab GM, Apolo AB, Motzer RJ; CheckMate 9ER Investigators. Choueiri TK, et al. N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982. N Engl J Med. 2021. PMID: 33657295 Free PMC article. Clinical Trial.
Pathology and gene mutations of aldosterone-producing lesions.
Nishimoto K, Ogishima T, Sugiura Y, Suematsu M, Mukai K. Nishimoto K, et al. Endocr J. 2023 Dec 28;70(12):1113-1122. doi: 10.1507/endocrj.EJ22-0492. Epub 2023 Sep 26. Endocr J. 2023. PMID: 37766569 Free article. Review.
Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M, Umezawa Y, Oya M, Kosaka T, Seki M, Suzuki Y, Horiuchi Y, Ogawa Y, Nishimoto K. Iwahashi N, et al. Among authors: nishimoto k. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2439-2448. doi: 10.1210/clinem/dgac394. J Clin Endocrinol Metab. 2022. PMID: 35796577 Free PMC article.
Test-retest repeatability of quantitative bone SPECT/CT.
Yamane T, Fukushima K, Shirotake S, Nishimoto K, Okabe T, Oyama M, Seto A, Kuji I. Yamane T, et al. Among authors: nishimoto k. Ann Nucl Med. 2021 Mar;35(3):338-346. doi: 10.1007/s12149-020-01568-2. Epub 2021 Jan 5. Ann Nucl Med. 2021. PMID: 33400148
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.
Kato T, Matsubara N, Shiota M, Eto M, Osawa T, Abe T, Shinohara N, Yasumizu Y, Tanaka N, Oya M, Nishimoto K, Hayashi T, Nakayama M, Kojima T, Namikawa K, Fujisawa T, Okano S, Hida E, Nakamura Y, Bando H, Yoshino T, Nonomura N. Kato T, et al. Among authors: nishimoto k. BMC Cancer. 2022 Dec 9;22(1):1292. doi: 10.1186/s12885-022-10398-6. BMC Cancer. 2022. PMID: 36494792 Free PMC article. Clinical Trial.
Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K, Koga M, Seki T, Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE, Naruse M, Sakaguchi T, Morita S, Kosaka T, Oya M, Ogishima T, Yasuda M, Suematsu M, Kabe Y, Omura M, Nishikawa T, Mukai K. Nishimoto K, et al. Mol Cell Endocrinol. 2017 Feb 5;441:124-133. doi: 10.1016/j.mce.2016.10.014. Epub 2016 Oct 14. Mol Cell Endocrinol. 2017. PMID: 27751767 Free PMC article. Review.
100 results